Safety Alerts for Human Medical Products > Gilenya (fingolimod) - FDA Warns About Cases of Rare Brain Infection
Heads-up from the FDA - Cases of progressive multifocal leukoencephalopathy (PML) in two patients with no prior exposure to immunosuppressant drugs. ...and the stock price of Novartis is temporarily doomed.
Continue Reading http://www.fda.gov
Additional Contributions:
Join the Discussion